Analysis on normative problems of Chinese patent medicine feeding and quality risk prevention and control strategy
In recent years,the quality of Chinese patent medicine(CPM)is generally good.However,due to the imperfect quality standards of some varieties,qualified products can be produced without feeding according to the standard process.The quality risk of CPM is objective,and the production link is the key point of whole life cycle supervision.In order to ensure the quality controllability,use safety and treatment effectiveness of CPM,it is urgent to monitor the quality risk of CPM based on feeding standardization.Based on previous work experiences and literature reports,this paper analyzes the problems of feeding,and discusses the challenges&strategies of risk management.It is expected that this study will improve the standardization of CPM feeding,prevent quality risks,and promote the high-quality development of CPM industry.
万方数据
维普
